SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-106821
Filing Date
2022-04-15
Accepted
2022-04-15 16:22:42
Documents
14
Period of Report
2022-04-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d315627d8k.htm   iXBRL 8-K 25018
2 EX-5.1 d315627dex51.htm EX-5.1 52082
6 GRAPHIC g315627g0217193357994.jpg GRAPHIC 1532
  Complete submission text file 0001193125-22-106821.txt   207386

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20220415.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20220415_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20220415_pre.xml EX-101.PRE 10818
8 EXTRACTED XBRL INSTANCE DOCUMENT d315627d8k_htm.xml XML 3298
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 22830246
SIC: 2834 Pharmaceutical Preparations